{"disease":{"id":"varicella","name":"Varicella","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":5,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"acyclovir-sodium","indication_name":"Varicella-Zoster in Immunocompromised Patients","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"ACYCLOVIR SODIUM","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":35,"revenue":null,"mechanism":null},{"drug_id":"vaccine-administration","indication_name":"Varicella","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vaccine Support Cp","generic_name":"Vaccine administration","company_name":"Women and Infants Hospital of Rhode Island","drug_phase":"marketed","molecular_target":"unknown","drug_class":"vaccine","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Varicella (chickenpox)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Varicella (chickenpox) booster","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Varicella (chickenpox) booster (immunocompromised)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Varicella (chickenpox) booster (pregnancy)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Varicella (chickenpox) booster (adolescent)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Varicella (chickenpox) booster (adult)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Varicella (chickenpox) booster (immunocompromised)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Varicella (chickenpox) booster (pregnancy)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Varicella (chickenpox) booster (adolescent)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"aciclovir","indication_name":"Varicella","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Aciclovir","company_name":"Assistance Publique Hopitaux De Marseille","drug_phase":"marketed","molecular_target":"Purine nucleoside phosphorylase, DNA polymerase catalytic subunit, Purine nucleoside phosphorylase","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"acyclovir","indication_name":"Varicella","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zovirax","generic_name":"ACYCLOVIR","company_name":"Ligand Pharms","drug_phase":"marketed","molecular_target":"Purine nucleoside phosphorylase","drug_class":"Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]","quality_score":80,"revenue":null,"mechanism":"Acyclovir works by mimicking a building block of DNA to prevent the herpes virus from replicating."},{"drug_id":"valacyclovir","indication_name":"Chickenpox (Varicella)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"VALACYCLOVIR","company_name":"","drug_phase":"marketed","molecular_target":"Viral DNA polymerase","drug_class":"Nucleoside analogue","quality_score":80,"revenue":null,"mechanism":"Valacyclovir is an antiviral drug that inhibits viral DNA polymerase to treat herpes simplex and varicella-zoster viruses."},{"drug_id":"valaciclovir","indication_name":"Varicella","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Valtrex","generic_name":"valaciclovir","company_name":"GSK","drug_phase":"marketed","molecular_target":"","drug_class":"Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor","quality_score":60,"revenue":null,"mechanism":"Valtrex works by inhibiting the replication of herpes simplex virus DNA through interference with viral DNA polymerase."},{"drug_id":"acyc","indication_name":"Varicella","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"ACYC","company_name":"Ligand Pharms","drug_phase":"marketed","molecular_target":"Purine nucleoside phosphorylase, DNA polymerase catalytic subunit, Purine nucleoside phosphorylase","drug_class":"","quality_score":null,"revenue":null,"mechanism":"Acyc works by binding to a specific target in the body, although its exact mechanism is unknown."}],"pipeline":[],"offLabel":[],"totalMarketed":16,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04471493","title":"Pediatric and Ambulatory Research in Infectious Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":400000,"lead_sponsor_name":"Association Clinique Thérapeutique Infantile du val de Marne","has_results":false},{"nct_id":"NCT05470855","title":"Protective Effect, Safety and Immunogenicity of Live Attenuated Varicella Vaccine in Anhui Province","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":45400,"lead_sponsor_name":"Sinovac (Dalian) Vaccine Technology Co., Ltd.","has_results":false},{"nct_id":"NCT05460429","title":"Immunogenicity, Safety and Protective Effect of Live Attenuated Varicella Vaccine and Study on Antibody Level and Etiology of Varicella Zoster Virus","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":37920,"lead_sponsor_name":"Sinovac (Dalian) Vaccine Technology Co., Ltd.","has_results":false},{"nct_id":"NCT05669625","title":"A Phase III Clinical Trial to Evaluate the Efficacy and Safety of the Live Attenuated Varicella Vaccine","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":12440,"lead_sponsor_name":"China National Biotec Group Company Limited","has_results":false},{"nct_id":"NCT07358910","title":"Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Institut Pasteur du Cambodge","has_results":false},{"nct_id":"NCT01077804","title":"A Study to Evaluate Long-term Impact of VARIVAX Among Children and Adolescents (V210-036)(COMPLETED)","phase":"","overall_status":"COMPLETED","enrollment_count":7585,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT00226499","title":"Evaluate Vaccine Against Chickenpox and a Combined Vaccine Against 4 Viral Childhood Diseases: Measles, Mumps, Rubella and Chickenpox","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":5803,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT00560755","title":"Safety Study of ProQuad® rHA in Infants (V221-037)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":3388,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT05158777","title":"Safety and Immunogenicity of Live Attenuated Varicella Vaccine in Healthy Population Aged ≥13 Years Old","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":2480,"lead_sponsor_name":"Shanghai Institute Of Biological Products","has_results":false},{"nct_id":"NCT05015686","title":"Safety and Immunogenicity of Live Attenuated Varicella Vaccine in Healthy Population Aged ≥13 Years Old","phase":"PHASE3","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":2400,"lead_sponsor_name":"Sinovac (Dalian) Vaccine Technology Co., Ltd.","has_results":false},{"nct_id":"NCT00578175","title":"Immunogenicity and Safety of GlaxoSmithKline Biologicals' MMRV Vaccine vs. ProQuad® in Children 12-14 Months of Age","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":1851,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT00566527","title":"Comparative Study of Immunogenicity and Safety of a 2-dose Regimen of ProQuad® Manufactured With rHA (V221-038)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1620,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT01536405","title":"Safety, Tolerability, and Immunogenicity of Measles, Mumps, Rubella, and Varicella (MMRV) Vaccine Made With an Alternative Manufacturing Process (AMP)(V221-027)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1412,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT02570126","title":"A Safety and Immune Study of 2 Types of GlaxoSmithKline's Varicella Vaccines Given as a 2-doses Course to Healthy Children 12-23 Months of Age.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1236,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT05839301","title":"A Trial to Evaluate the Lot-to-lot Consistency of Live Attenuated Varicella Vaccine in Healthy People 1-12 Years of Age","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":1200,"lead_sponsor_name":"China National Biotec Group Company Limited","has_results":false},{"nct_id":"NCT00092430","title":"Study to Evaluate Frozen Versus Refrigerated MMRV (Combined Measles, Mumps, Rubella, and Varicella) Investigational Vaccine (V221-016)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1200,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":false},{"nct_id":"NCT03555071","title":"A Phase 3 Lot-consistency Clinical Trial of Live Attenuated Varicella Vaccine","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1197,"lead_sponsor_name":"Sinovac (Dalian) Vaccine Technology Co., Ltd.","has_results":false},{"nct_id":"NCT05150392","title":"An Open-labelled Clinical Trial of Live Attenuated Varicella Vaccines to Evaluate the Immunity Persistence After Primary Immunization and Safety and Immunogenicity After the Booster Immunization","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1193,"lead_sponsor_name":"Sinovac (Dalian) Vaccine Technology Co., Ltd.","has_results":false},{"nct_id":"NCT00432042","title":"Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered Concomitantly (V221-035)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":955,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT06987942","title":"Simultaneous Administration Study of Varicella Attenuated Live Vaccine and Trivalent Inactivated Influenza Vaccine (Split Virion)","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":899,"lead_sponsor_name":"Sinovac (Dalian) Vaccine Technology Co., Ltd.","has_results":false},{"nct_id":"NCT04398706","title":"Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":852,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT07415252","title":"SkyVaricella® (NBP608) Vaccine With Lower Potencies in Healthy Children Aged 12 Months to 12 Years","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":780,"lead_sponsor_name":"SK Bioscience Co., Ltd.","has_results":false},{"nct_id":"NCT00432523","title":"Immunogenicity and Safety of Concomitant Administration of MMR™ rHA and VARIVAX® by Intramuscular Versus Subcutaneous Route (V205C-011)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":752,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":false},{"nct_id":"NCT01506193","title":"Immunogenicity and Safety Study of PriorixTetra™ When Co-administered With Conjugated MenC Vaccine in Healthy Children","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":716,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT05095701","title":"An Immunity Persistence Study of Live Attenuated Varicella Vaccine","phase":"PHASE4","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":703,"lead_sponsor_name":"Sinovac (Dalian) Vaccine Technology Co., Ltd.","has_results":false},{"nct_id":"NCT06314724","title":"Immunogenicity and Safety of Varicella Vaccine, Live in Healthy Children Aged 12~15 Months in the Philippines","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":642,"lead_sponsor_name":"Sinovac (Dalian) Vaccine Technology Co., Ltd.","has_results":false},{"nct_id":"NCT02062502","title":"Evaluation of Immunogenicity and Safety of VARIVAX™ New Seed Process (NSP) in Children (V210-063)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":611,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT03239873","title":"Evaluation of Immunogenicity and Safety of VARIVAX® Passage Extension 34 (PE34) Process in Children (V210-A03)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":600,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT05705180","title":"The Influence of Trained Immunity in COVID-19 Vaccinated Individuals","phase":"","overall_status":"UNKNOWN","enrollment_count":600,"lead_sponsor_name":"Wuerzburg University Hospital","has_results":false},{"nct_id":"NCT03114943","title":"Immunogenicity and Safety of NBP608 Compared to Varivax in Healthy Children 12 Months to 12 Years of Age","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":516,"lead_sponsor_name":"SK Bioscience Co., Ltd.","has_results":false},{"nct_id":"NCT00892775","title":"Immunogenicity & Safety Study of GSK Biologicals' 208136 Vaccine Formulated With New Measles and Rubella Working Seeds","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":501,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT00751348","title":"Immunogenicity & Safety Study of GSK Biologicals' Combined Measles-mumps-rubella-varicella Vaccine 208136","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":475,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT01190228","title":"Study of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children Previously Immunized With JE-CV","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":454,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT05526820","title":"A Study of Combined Immunization With Live Attenuated Varicella Vaccine and Inactivated Hepatitis A Vaccine","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":450,"lead_sponsor_name":"Sinovac (Dalian) Vaccine Technology Co., Ltd.","has_results":false},{"nct_id":"NCT00969436","title":"Comparison of GSK Measles-mumps-rubella-varicella (MMRV) Vaccine Versus PriorixTM","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":450,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT06994052","title":"Study on Booster Immunization With Varicella Vaccine at Different Intervals","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":412,"lead_sponsor_name":"Sinovac (Dalian) Vaccine Technology Co., Ltd.","has_results":false},{"nct_id":"NCT00402831","title":"ProQuad® Intramuscular vs Subcutaneous","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":405,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT06075732","title":"ACTIVATE in Public Housing","phase":"NA","overall_status":"COMPLETED","enrollment_count":400,"lead_sponsor_name":"Charles Drew University of Medicine and Science","has_results":false},{"nct_id":"NCT06482216","title":"Correlation of Protection Against Varicella in an Exploratory Study","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":400,"lead_sponsor_name":"Sinovac (Dalian) Vaccine Technology Co., Ltd.","has_results":false},{"nct_id":"NCT07473427","title":"Immunogenicity and Safety of Varicella Vaccine, Live in Healthy Vietnamese Children Aged 1~12 Years: A Single-armed Bridging Clinical Trial","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":300,"lead_sponsor_name":"Sinovac (Dalian) Vaccine Technology Co., Ltd.","has_results":false},{"nct_id":"NCT07475000","title":"Second Dose of Varicella Vaccine in Healthy Children","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Sinovac (Dalian) Vaccine Technology Co., Ltd.","has_results":false},{"nct_id":"NCT07285278","title":"Phase II Clinical Trial of Lyophilized Herpes Zoster mRNA Vaccine in Adults Aged 40 Years or Above","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":300,"lead_sponsor_name":"Suzhou Abogen Biosciences Co., Ltd.","has_results":false},{"nct_id":"NCT05604911","title":"Herpes Virus Infections in Kidney Transplant Patients","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":280,"lead_sponsor_name":"Susanne Dam Nielsen, MD, DMSc","has_results":false},{"nct_id":"NCT03330171","title":"Safety and Immunogenicity of Measles Vaccine, Varicella Vaccine and Hepatitis-A Vaccine","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":278,"lead_sponsor_name":"University of Witwatersrand, South Africa","has_results":false},{"nct_id":"NCT00568334","title":"Study of Two Formulations of GSK Biologicals' Varicella Vaccine","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":244,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT05198570","title":"Pharmacokinetics of Intravenous Acyclovir in Oncologic Paediatric Patients","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"University of Pisa","has_results":false},{"nct_id":"NCT07285265","title":"Phase I Clinical Trial of Lyophilized Herpes Zoster mRNA Vaccine in Adults Aged 40 Years or Above","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":180,"lead_sponsor_name":"Suzhou Abogen Biosciences Co., Ltd.","has_results":false},{"nct_id":"NCT03843632","title":"Evaluation of the Immunogenicity and Safety of VARIVAX™ in Healthy Russians (V210-058)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT03178747","title":"Tzanck Smear With Methylene Blue Stain for Herpes","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"Chulalongkorn University","has_results":false},{"nct_id":"NCT05924685","title":"PREPARE-iVAC Trial","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":110,"lead_sponsor_name":"University Medical Center Groningen","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}